FINWIRES · TerminalLIVE
FINWIRES

Caliway Completes FDA IND Filing for Phase 3b CBL-514 Trial of Abdominal Fat Reduction Drug

By

Caliway Biopharmaceuticals (TPE:6919) completed its U.S. FDA IND submission for a Phase 3b long-term follow-up study of its abdominal subcutaneous fat reduction drug, according to a Wednesday Taiwan Exchange filing.

The study, dubbed CBL-0303, is designed to evaluate long-term safety and maintenance of efficacy of the drug called CBL-514, before the trail.

It is expected to enroll around 300 participants in the United States. The protocol also includes an optional re-treatment phase for eligible patients, the filing said.

Related Articles

Asia

Tansun Technology Invests 100 Million Yuan in Hongma Multidimensional Fund

Tansun Technology Co (SHE:300872) invested 100 million yuan in the Hongma Multidimensional Fund as a limited partner.After the transaction, the fund will have a total committed capital of 309 million yuan, giving the company a 32.36% stake, according to a Thursday filing with the Shenzhen bourse.Shares of the information technology company closed 2% lower Thursday.

$SHE:300872
Asia

Sunwill Precising Plastic to Raise Proceeds of 242 Million Yuan From Share Placement

Guangdong Sunwill Precising Plastic (SHE:002676) plans to raise proceeds worth up to 242.3 million yuan through a share placement, according to a Shenzhen bourse filing on Thursday.The proceeds will be used for the upgrade of an automated intelligent manufacturing base for fan blades and the construction of a high-performance modified composite materials plant, as well as for the supplementation of the company's working capital.The Chinese plastic air-conditioning fan blades producer's shares rose 3% at the close.

$SHE:002676
Asia

Willowglen MSC Unit Bags MYR39 Million DMS System Deal

Willowglen MSC (KLSE:WILLOW) unit Willowglen Services secured a deal worth about 39.4 million ringgit for the refresh of Distribution Management System (DMS) partial discharge monitoring systems in Singapore.The deal was awarded by SP PowerAssets, according to a Wednesday Malaysian bourse filing.The contract is scheduled to run until Dec. 2, 2034, and the project is expected to contribute positively to the group's earnings, it said.

$KLSE:WILLOW